Literature DB >> 24646483

Herb-drug interactions in oncology.

A K L Goey1, J H Beijnen2, J H M Schellens3.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24646483     DOI： 10.1038/clpt.2014.18

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  7 in total

1.  Identifying Drug Interactions between Enzalutamide and Complementary Alternative Medications in a Patient with Metastatic Prostate Cancer: A Case Report.

Authors:  Thomas Brownlee; Colleen Olson; Michelle Deschamps
Journal:  Can J Hosp Pharm       Date:  2018-08-28

2.  An ex vivo approach to botanical-drug interactions: a proof of concept study.

Authors:  Xinwen Wang; Hao-Jie Zhu; Juliana Munoz; Bill J Gurley; John S Markowitz
Journal:  J Ethnopharmacol       Date:  2015-01-24       Impact factor: 4.360

3.  Use of Medicinal Plants by Cancer Patients Under Chemotherapy in the Northwest of Morocco (Rabat Area) : Cross-Sectional Study.

Authors:  Nadia El Orfi; Saber Boutayeb; Bouchra Haddou Rahou; Hassan Errihani
Journal:  J Evid Based Integr Med       Date:  2022 Jan-Dec

4.  An assessment of the impact of herb-drug combinations used by cancer patients.

Authors:  Saud M Alsanad; Rachel L Howard; Elizabeth M Williamson
Journal:  BMC Complement Altern Med       Date:  2016-10-18       Impact factor: 3.659

5.  Inhibition of Human Cytochrome P450 Enzymes by Allergen Removed Rhus verniciflua Stoke Standardized Extract and Constituents.

Authors:  Hyunsik Jung; Sanghun Lee
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-30       Impact factor: 2.629

6.  The Effect of Undaria pinnatifida Fucoidan on the Pharmacokinetics of Letrozole and Tamoxifen in Patients With Breast Cancer.

Authors:  Shreya Tocaciu; Lesley J Oliver; Ray M Lowenthal; Gregory M Peterson; Rahul Patel; Madhur Shastri; Georgia McGuinness; Inger Olesen; J Helen Fitton
Journal:  Integr Cancer Ther       Date:  2016-12-23       Impact factor: 3.279

Review 7.  Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics.

Authors:  Femke M de Man; Andrew K L Goey; Ron H N van Schaik; Ron H J Mathijssen; Sander Bins
Journal:  Clin Pharmacokinet       Date:  2018-10       Impact factor: 6.447
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.